(HealthDay)—A four-month rifapentine-based regimen containing moxifloxacin is noninferior to a standard six-month regimen for treatment of tuberculosis, according to a study published in the May 6 […]
German firm BioNTech said Thursday that patent protection for COVID-19 vaccines is not holding back production or supply of the jabs that it developed with Pfizer.
Vaccination dramatically reduced COVID-19 symptomatic and asymptomatic infections in St. Jude Children’s Research Hospital employees compared with their unvaccinated peers, according to a research letter that […]